178 related articles for article (PubMed ID: 37731642)
1. Prognostic significance of C-reactive protein in patients with cervical cancer: a meta-analysis.
Yang S; Zhang Z; Shen L
Front Oncol; 2023; 13():1232409. PubMed ID: 37731642
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis.
Zhang W; Zhang Z; Qian L
World J Surg Oncol; 2024 Jan; 22(1):8. PubMed ID: 38172843
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis.
Zhou K; Li C; Chen T; Zhang X; Ma B
Front Endocrinol (Lausanne); 2023; 14():1111277. PubMed ID: 36817592
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Hematological Markers for Patients with Nasopharyngeal Carcinoma: A Meta-analysis.
Yang S; Zhao K; Ding X; Jiang H; Lu H
J Cancer; 2019; 10(11):2568-2577. PubMed ID: 31258763
[No Abstract] [Full Text] [Related]
6. Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Huang Z; Wang K; Huang S; Lu Q
Transl Cancer Res; 2023 Aug; 12(8):2169-2180. PubMed ID: 37701105
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.
Mao H; Yang F
Front Oncol; 2023; 13():1193962. PubMed ID: 37342198
[TBL] [Abstract][Full Text] [Related]
8. Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis.
Luo Y; Fu SJ; She DL; Xiong HU; Yang LI
Mol Clin Oncol; 2015 Jul; 3(4):924-928. PubMed ID: 26171208
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
Chen Y; Cong R; Ji C; Ruan W
Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of the C-Reactive Protein/Albumin Ratio in Patients With Gynecological Cancers: A Meta-Analysis.
Fang Y; Zheng T; Zhang C
Front Oncol; 2021; 11():737155. PubMed ID: 34778051
[TBL] [Abstract][Full Text] [Related]
12. An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis.
Liu C; Guo H; Mao H; Tong J; Yang M; Yan X
Front Oncol; 2022; 12():753234. PubMed ID: 35280736
[TBL] [Abstract][Full Text] [Related]
13. Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis.
Zhao H; Liu CH; Cao Y; Zhang LY; Zhao Y; Liu YW; Liu HF; Lin YS; Li XY
Front Oncol; 2022; 12():990154. PubMed ID: 36591452
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of C-Reactive Protein to Albumin Ratio in Gastric Cancer: A Meta-Analysis.
Yue L; Lu Y; Li Y; Wang Y
Nutr Cancer; 2021; 73(10):1864-1871. PubMed ID: 32940549
[TBL] [Abstract][Full Text] [Related]
15. C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.
Yang Y; Li X; Qian H; Di G; Zhou R; Dong Y; Chen W; Ren Q
Comput Intell Neurosci; 2022; 2022():6833078. PubMed ID: 36268143
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis.
Zhao N; Xu H; Zhou D; Xu X; Ge W; Cao D
J Gastrointest Oncol; 2022 Aug; 13(4):1772-1781. PubMed ID: 36092324
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis.
Zhou K; Cao J; Lin H; Liang L; Shen Z; Wang L; Peng Z; Mei J
Front Oncol; 2022; 12():962173. PubMed ID: 36059629
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
Gao N; Yang RN; Meng Z; Wang WH
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
[TBL] [Abstract][Full Text] [Related]
19. The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.
Han CL; Meng GX; Ding ZN; Dong ZR; Chen ZQ; Hong JG; Yan LJ; Liu H; Tian BW; Yang LS; Xue JS; Li T
Front Immunol; 2022; 13():827788. PubMed ID: 35211122
[TBL] [Abstract][Full Text] [Related]
20. Association between baseline C‑reactive protein level and survival outcomes for cancer patients treated with immunotherapy: A meta‑analysis.
Xu Y; Ma K; Zhang F; Ma M; Hong L; Wang J; Li S; Sun P; Wang J; Wei S
Exp Ther Med; 2023 Aug; 26(2):361. PubMed ID: 37408861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
